Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses
Sham Nambulli, Yufei Xiang, Natasha L. Tilston‐Lunel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 13

Showing 13 citing articles:

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 164
SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2
Lu Qiao, Jia Liu, Shuai Zhao, et al.
Immunity (2021) Vol. 54, Iss. 6, pp. 1304-1319.e9
Open Access | Times Cited: 145
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
James Brett Case, Rita E. Chen, Longxing Cao, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1151-1161.e5
Open Access | Times Cited: 55
Prospects of Neutralizing Nanobodies Against SARS-CoV-2
Fangfang Chen, Zhihong Liu, Fan Jiang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 36
Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidates
Marcel Walser, Sylvia Rothenberger, Daniel L. Hurdiss, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 34
Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines
Theron Gilliland, Yanan Liu, Rong Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes
Dapeng Sun, Zhe Sang, Yong Joon Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate
Gang Ye, Fan Bu, Divyasha Saxena, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012726-e1012726
Open Access | Times Cited: 1
Influence of mesh nebulizer characteristics on aerosol delivery in non-human primates
María Cabrera, Déborah Le Pennec, Sandrine Le Guellec, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 191, pp. 106606-106606
Open Access | Times Cited: 3
Arsenal of Nanobodies for Broad-Spectrum Countermeasures against Current and Future SARS-CoV-2 Variants of Concerns
Martín A. Rossotti, Henk van Faassen, Anh Tran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2
Anna R. Mäkelä, Hasan Uğurlu, Liina Hannula, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 2
Intratracheal trimerized nanobody cocktail protects against SARS-CoV-2 Omicron in mice
Kayoko Nagata, Daichi Utsumi, Masamitsu N. Asaka, et al.
Research Square (Research Square) (2022)
Open Access
Discovery of nanobodies against SARS-CoV-2 and an uncommon neutralizing mechanism
Tingting Li, Bingjie Zhou, Zhipu Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access
Page 1

Scroll to top